REGENERON PHARMACEUTICALS, INC. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 416.24 | 3,000 | 1,248,720 | 4,481 | 7.5 K to 4.5 K (-40.10 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 30.63 | 24,375 | 746,606 | 53,611 | |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 423.67 | 11,173 | 4,733,665 | 20,029 | 31.2 K to 20 K (-35.81 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 427.94 | 11,458 | 4,903,337 | 31,202 | 42.7 K to 31.2 K (-26.86 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 427.94 | 1,744 | 746,327 | 42,660 | 44.4 K to 42.7 K (-3.93 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 30.63 | 24,375 | 746,606 | 44,404 | 20 K to 44.4 K (+121.70 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 18.61 | 15,000 | 279,150 | 0 | |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 423.12 | 15,000 | 6,346,800 | 112,772 | 127.8 K to 112.8 K (-11.74 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 18.61 | 15,000 | 279,150 | 127,772 | 112.8 K to 127.8 K (+13.30 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 20,000 | 425,000 | 17,895 | |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 429.09 | 3,331 | 1,429,299 | 18,705 | 22 K to 18.7 K (-15.12 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 428.27 | 2,100 | 899,367 | 22,036 | 24.1 K to 22 K (-8.70 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 427.12 | 1,700 | 726,104 | 24,136 | 25.8 K to 24.1 K (-6.58 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 426.08 | 2,300 | 979,984 | 25,836 | 28.1 K to 25.8 K (-8.17 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 424.70 | 9,569 | 4,063,954 | 28,136 | 37.7 K to 28.1 K (-25.38 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 424.70 | 1,000 | 424,700 | 37,705 | 38.7 K to 37.7 K (-2.58 %) |
| Feb 24 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 20,000 | 425,000 | 38,705 | 18.7 K to 38.7 K (+106.92 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 57.11 | 1,000 | 57,110 | 8,000 | |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 422.72 | 1,000 | 422,720 | 0 | 1,000 to 0 (-100.00 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 57.11 | 1,000 | 57,110 | 1,000 | 0 to 1,000 |
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 50.91 | 3,000 | 152,730 | 9,279 | |
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 424.44 | 300 | 127,332 | 1,187 | 1.5 K to 1.2 K (-20.17 %) |
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 423.64 | 1,100 | 466,004 | 1,487 | 2.6 K to 1.5 K (-42.52 %) |
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 420.33 | 1,600 | 672,528 | 2,587 | 4.2 K to 2.6 K (-38.21 %) |
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 50.91 | 3,000 | 152,730 | 4,187 | 1.2 K to 4.2 K (+252.74 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 30.63 | 7,500 | 229,725 | 7,500 | |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 420.64 | 400 | 168,256 | 18,600 | 19 K to 18.6 K (-2.11 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 419.52 | 1,103 | 462,731 | 19,000 | 20.1 K to 19 K (-5.49 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 418.33 | 800 | 334,664 | 20,103 | 20.9 K to 20.1 K (-3.83 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 417.23 | 471 | 196,515 | 20,903 | 21.4 K to 20.9 K (-2.20 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 416.31 | 600 | 249,786 | 21,374 | 22 K to 21.4 K (-2.73 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 427.94 | 3,590 | 1,536,305 | 21,974 | 25.6 K to 22 K (-14.04 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 427.94 | 536 | 229,376 | 25,564 | 26.1 K to 25.6 K (-2.05 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 30.63 | 7,500 | 229,725 | 26,100 | 18.6 K to 26.1 K (+40.32 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 273.67 | 4,250 | 1,163,098 | 8,500 | |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 177.82 | 10,000 | 1,778,200 | 5,000 | |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 57.11 | 10,000 | 571,100 | 0 | |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | M | 33.42 | 5,000 | 167,100 | 0 | |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 424.58 | 750 | 318,435 | 47,500 | 48.3 K to 47.5 K (-1.55 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 423.31 | 18,174 | 7,693,236 | 48,250 | 66.4 K to 48.3 K (-27.36 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 422.52 | 8,196 | 3,462,974 | 66,424 | 74.6 K to 66.4 K (-10.98 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 421.72 | 2,130 | 898,264 | 74,620 | 76.8 K to 74.6 K (-2.78 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 33.42 | 5,000 | 167,100 | 76,750 | 71.8 K to 76.8 K (+6.97 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 57.11 | 10,000 | 571,100 | 71,750 | 61.8 K to 71.8 K (+16.19 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 177.82 | 10,000 | 1,778,200 | 61,750 | 51.8 K to 61.8 K (+19.32 %) |
| Feb 23 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Buy | M | 273.67 | 4,250 | 1,163,098 | 51,750 | 47.5 K to 51.8 K (+8.95 %) |
| Feb 20 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 177.82 | 5,000 | 889,100 | 5,000 | |
| Feb 20 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 423.61 | 4,600 | 1,948,606 | 4,000 | 8.6 K to 4 K (-53.49 %) |
| Feb 20 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 424.14 | 400 | 169,656 | 8,600 | 9 K to 8.6 K (-4.44 %) |
| Feb 20 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 177.82 | 5,000 | 889,100 | 9,000 | 4 K to 9 K (+125.00 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 7,500 | 180,000 | 21,668 | |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 406.24 | 100 | 40,624 | 18,600 | 18.7 K to 18.6 K (-0.53 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 405.56 | 900 | 365,004 | 18,700 | 19.6 K to 18.7 K (-4.59 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 404.55 | 1,692 | 684,499 | 19,600 | 21.3 K to 19.6 K (-7.95 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 403.72 | 600 | 242,232 | 21,292 | 21.9 K to 21.3 K (-2.74 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 402.51 | 300 | 120,753 | 21,892 | 22.2 K to 21.9 K (-1.35 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 401.54 | 100 | 40,154 | 22,192 | 22.3 K to 22.2 K (-0.45 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 402.05 | 3,361 | 1,351,290 | 22,292 | 25.7 K to 22.3 K (-13.10 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 402.05 | 447 | 179,716 | 25,653 | 26.1 K to 25.7 K (-1.71 %) |
| Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 7,500 | 180,000 | 26,100 | 18.6 K to 26.1 K (+40.32 %) |